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Abstract
Phosphatase and tensin homolog (PTEN) plays an important role in tumor suppression. A germline mutation in the
PTEN gene induces not only PTEN hamartoma tumor syndrome, including Cowden syndrome, but also macrocephaly/
autism syndrome. Here, we describe a boy with macrocephaly/autism syndrome harboring a novel missense
heterozygous PTEN mutation, c.959T>C (p.Leu320Ser). Interestingly, a previously reported nonsense mutation resulting
in p.Leu320X was found in Cowden syndrome patients. Our case may be suggestive of a genotype-phenotype
correlation.
The phosphatase and tensin homolog (PTEN) gene
(OMIM 601728), located on chromosome 10q23, is a tumor
suppressor gene that has a significant role in cellular pro-
liferation, migration, and apoptosis1. PTEN hamartoma
tumor syndrome (PHTS), which comprises Cowden syn-
drome (CS; OMIM 158350), Bannayan–Riley–Ruvalcaba
syndrome (BRRS; OMIM 153480), and Proteus-like syn-
drome, represents a spectrum of hamartomatous over-
growth manifestations associated with germline mutations
in the PTEN gene2. CS is characterized by macrocephaly,
trichilemmomas, facial acral keratosis, hamartoma, and an
increased risk of certain cancers, particularly of the breast,
uterus, and thyroid3. Under revised diagnostic criteria, the
majority of CS diagnoses are made in adulthood because
cutaneous findings or malignancies are rarely present before
20 years of age4. BRRS is typically diagnosed in childhood
and is characterized by macrocephaly, hamartomas
(including lipomas or intestinal polyps), penile freckling in
males and developmental delays, including an increased risk
of autism spectrum disorder (ASD). Because the clinical
presentation of CS and BRRS is quite similar, they were
considered to be a single disorder with variable phenotypic
expression and age-related penetrance5. However, the
clinical features of patients with PTEN mutations were
quite variable, and presentations differed significantly even
within the same family6.
PTEN mutations have been identified in children with
macrocephaly associated with ASD and/or developmental
delay without hamartomas known as macrocephaly/aut-
ism syndrome (OMIM 605309)7,8. However, the clinical
features of these children have not been described in
detail. We report here a 4-year-old boy with macro-
cephaly and developmental delay that had a novel mis-
sense mutation, NM_000314.4:c.959T>C [p.(Leu320Ser)],
in the PTEN gene.
The patient was the first child of healthy non-
consanguineous Japanese parents. Family history was
unremarkable. He was born after 38 weeks of gestation
using vacuum extraction with a birth weight of 3.696 g
(+1.7 SD), length of 52 cm (+1.4 SD) and head cir-
cumference of 37 cm (+2.6 SD). He could control his
head at 5 months but was referred to our hospital for
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developmental delay and muscular hypotonia at
10 months of age.
His head circumference was 50.0 cm (+2.8 SD) at
10 months old. His anterior fontanelle was widely open
with a prominent forehead, but he did not have any
symptoms related to increased intracranial pressure, such
as vomiting, seizures, or poor activity. He showed loose
shoulder and heel to ear sign, suggesting general muscular
hypotonus. Physical examination did not reveal heart
murmur, organomegaly, cutaneous pigmentary lesions, or
freckles on the penis. The overall developmental quotient
was 60 by the Kinder Infant Development Scale9. Head
MRI at 10 months showed white matter hyperintense
areas on T2 weighted and fluid-attenuated inversion
recovery (FLAIR) images, enlarged perivascular spaces,
mild ventricular enlargement, and narrow posterior fossa
(Fig. 1). The possibility of hydrocephalus was excluded
after cisternography at 1 year and 1 month of age. He
could walk alone at 1 year and 8 months of age. He spoke
the first meaningful word at 1 year and 5 months and two
phrases at 2 years and 6 months. The physical
examination at 4 years and 2 months of age showed a
weight of 17.4 kg (+0.7 SD), height of 104.0 cm (+0.7 SD),
and head circumference of 56.5 cm (+3.6 SD). Chromo-
somal analysis showed 46,XY.
A trio exome analysis was performed as described pre-
viously10. The research protocol was approved by the local
Institutional Ethical Review Board of the University of
Tsukuba and Keio University School of Medicine.
Informed consent was obtained from the parents on the
basis of the Declaration of Helsinki. Genomic DNA was
extracted from peripheral blood leukocytes of the patient
and his parents. Whole-exome sequencing using the Sur-
eSelectXT2 Human All Exon Kit V4 (Agilent Technolo-
gies, Santa Clara, CA) was performed on the HiSeq 1000
platform (Illumina, San Diego, CA) and showed a het-
erozygous missense mutation, NM_000314.4:c.959T>C,
[p.(Leu320Ser)] in exon 8 of PTEN (OMIM #601728) that
was confirmed by Sanger sequencing (Fig. 2). This muta-
tion was found only in the patient and not in his parents,
indicating that it was a de novo mutation. In silico analysis
demonstrated that this mutation was likely pathogenic
Fig. 1 Head MRI at 10 months of age. a Axial T2-weighted image and b coronal FLAIR image show hyperintensity in the bilateral periventricular
white matter regions (yellow arrowhead) and enlarged periventricular spaces (thin yellow arrow). c Sagittal T1-weighted image shows a narrow
posterior fossa (broad yellow arrow)
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(SIFT: deleterious, score 0; PolyPhen: probably damaging,
score 0.99; PROVEAN: damaging, score −4.2). To the best
of our knowledge, this mutation has never been reported
previously. Based on a literature review, the variants
c.959T>A and c.959T>G, which result in p.Leu320X, have
been previously reported in CS patients4,11.
In 2005, Butler et al.8 reported the presence of hetero-
zygous germline mutations in the PTEN gene in three
children with ASD and macrocephaly. Since then, germ-
line PTEN pathogenic variants have been reported in
10–20% of ASD cases with macrocephaly. Furthermore,
developmental delay, intellectual disability, and/or ASD
have been recorded in 66% of children with pathogenic
mutations in PTEN3.
Our patient presented with macrocephaly from birth,
whereas developmental delay and muscular hypotonia
without dermatological findings were noted from the
infantile period. His brain MRI was consistent with pre-
vious reports of individuals with PTEN mutations who
also presented with macrocephaly, developmental delay,
and/or ASD4. Whole-exome sequencing identified a novel
missense PTEN gene mutation, NM_000314.4:c.959T>C,
[p.(Leu320Ser)], in the patient. However, he did not meet
clinical criteria for BRRS or CS diagnoses. Although we
diagnosed him with macrocephaly/autism syndrome
provisionally, it is certainly possible that the patient will
meet the criteria for CS/BRRS in the future.
Many of the mutations associated with CS and BRRS
occur in exons 5, 7, and 8 of the PTEN gene11. Previous
studies of CS/BRRS cohorts have failed to establish clear
genotype-phenotype correlations3. Furthermore, Frazier
et al.12 reported that germline heterozygous missense
PTENmutations were enriched in ASD and macrocephaly
cases compared to their frequency in PHTS patients
without ASD. Interestingly, the missense mutation
Leu320Ser found in our patient was associated with
macrocephaly and developmental delay, whereas the
previously reported nonsense mutation Leu320X was
found in a CS patient. Our case may be suggestive of a
genotype-phenotype correlation even though we could
not confirm this on the basis of a single case report.
Further research is needed to ascertain this correlation.
The major concern in patients with PTEN mutations is a
risk of malignancy. To date, however, a consensus cancer
surveillance protocol has not been formally instituted, so all
PTEN mutation carriers should adopt the cancer surveil-
lance strategies proposed for patients with CS2. We started
annual general surveillance and annual specific surveillance
of thyroid cancer for future cancer risk in this patient.
In conclusion, we identified a novel missense PTEN
gene mutation in a Japanese boy who presented with
developmental delay and macrocephaly. We will continue
to follow up with this patient regularly for the early
detection of tumor development as well as to expand our
Fig. 2 PTEN sequences of the patient and his parents. The patient has a heterozygous missense mutation, NM_000314.4: c.959T>C, [p.
(Leu320Ser)] (arrow) in PTEN exon 8. This mutation was not found in his parents
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knowledge of genotype-phenotype correlations in patients
with pathological PTEN variants.
HGV Database
The relevant data from this Data Report are hosted at the Human Genome
Variation Database at https://doi.org/10.6084/m9.figshare.hgv.2579.
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